Physician

Mary G Petrick, MD

According to 2025 Medicare claims, Mary Petrick, MD (NPI: 1639134919) practices dermatology in the Williamsport, PA market, with the plurality of this provider's patient population coming from Lycoming, PA. This provider's primary affiliated billing organization is GEISINGER CLINIC (NPI: 1255382784; TIN: 236291113) and primary practice location at 17821-8029. Petrick is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Petrick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 411 traditional Medicare patients, billed 1,839 HCPCS/CPT codes, and received $175,854 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 170 prescription claims across 109 beneficiaries totaling $3,179 in drug costs, led by Fluorouracil (Fluorouracil). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $8,131 and ending at $3,179. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$95K$189K2015 Medicare payment: $159,074 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $189,488 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $179,342 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $186,710 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $189,341 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $160,596 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $135,527 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $141,430 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $162,061 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $175,854 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153201,886$159,074
20163652,031$189,488
20173891,873$179,342
20183421,982$186,710
20193611,961$189,341
20203681,782$160,596
20213221,554$135,527
20222991,562$141,430
20233311,655$162,061
20244111,839$175,854

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$7.6K$15K2015 Drug cost: $8,131 (USD; Tot_Drug_Cst)2016 Drug cost: $6,905 (USD; Tot_Drug_Cst)2017 Drug cost: $15,222 (USD; Tot_Drug_Cst)2018 Drug cost: $3,935 (USD; Tot_Drug_Cst)2019 Drug cost: $2,567 (USD; Tot_Drug_Cst)2020 Drug cost: $3,059 (USD; Tot_Drug_Cst)2021 Drug cost: $7,348 (USD; Tot_Drug_Cst)2022 Drug cost: $3,813 (USD; Tot_Drug_Cst)2023 Drug cost: $2,496 (USD; Tot_Drug_Cst)2024 Drug cost: $3,179 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201581111$8,131
201681123$6,905
201780105$15,222
20186683$3,935
20196187$2,567
20204981$3,059
20214159$7,348
20224769$3,813
20236598$2,496
2024109170$3,179

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks219271$221
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks100162$141
88331Pathology examination of specimen during surgery, first tissue block100177$44
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more160220$44
11102Biopsy of related skin growth, first growth125147$16

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil14474$1,556
MupirocinMupirocin981,697$935
KetoconazoleKetoconazole11260$186
CephalexinCephalexin19183$155

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Mary G. Petrick, MD?

Tedicare shows public-source Medicare data for Mary G. Petrick, MD (NPI 1639134919), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mary G. Petrick, MD have ACO affiliation data?

Mary G. Petrick, MD is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Mary G. Petrick, MD?

Mary G. Petrick, MD is linked to GEISINGER CLINIC (billing NPI 1255382784) in the available physician profile data.

Does Mary G. Petrick, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.